Latest News About Bayer

Here are the latest Bayer headlines I found across several reputable outlets:

• Bayer receives U.S. FDA priority review for Hyrnuo (sevabertinib) and related applications for HER2-mutated cancers, signaling potential near-term regulatory momentum in their oncology portfolio.[1][2]
• U.S. FDA grants priority review for sevabertinib as a first-line treatment in HER2-mutated non-small cell lung cancer, with concurrent Japanese reviews, highlighting ongoing global regulatory activity around Bayer’s targeted therapies.[2][1]
• Bayer reaches a settlement in a PCB cleanup-related matter in the United States, reflecting ongoing environmental and litigation-related exposures the company faces.[1]
• Market participants and analysts continue to weigh Bayer’s near-term prospects, with several firms maintaining Buy/Overweight stances and raising price targets on favorable earnings or pipeline signals.[1]

If you’d like, I can pull the most recent articles from specific outlets (e.g., Reuters, MarketScreener, Bayer’s own Newsroom) and summarize their key takeaways, or compile a quick, verified snapshot with dates and sources. Also, tell me if you want regional news (U.S., Europe) or sector-focused updates (drugs, agchem, litigation).

Would you like me to pull the exact current articles and provide a concise briefing with sources?